H2AJ Gene

Name H2A.J histone
Description Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene is located on chromosome 12 and encodes a replication-independent histone that is a variant H2A histone. The protein is divergent at the C-terminus compared to the consensus H2A histone family member. This gene also encodes an antimicrobial peptide with antibacterial and antifungal activity.[provided by RefSeq, Oct 2015]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n H2A.J, a mammalian‐specific variant of histone H2A, is emerging as a multifunctional regulator of chromatin structure and gene expression in diverse biological contexts. In senescent human fibroblasts, H2A.J accumulates in cells harboring persistent DNA damage and functions to promote the expression of pro‐inflammatory genes that characterize the senescence‐associated secretory phenotype, implicating it in chronic inflammation and aging‐related pathologies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Moreover, its cell type–restricted expression—most notably its enrichment in luminal epithelial cells of glands such as the breast, prostate, and pancreas—is being explored as a novel marker for luminal epithelial cancers."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Biochemical and structural analyses further reveal that H2A.J is efficiently incorporated into the nucleosome with specific residues (e.g., Ala40) contributing to modulations in nucleosome stability, suggesting that subtle changes in H2A.J structure may influence higher-order chromatin dynamics."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In addition to its roles in normal chromatin regulation, aberrant expression of H2A.J (often noted as H2AFJ) has been linked to cancer therapy resistance. Elevated levels of H2A.J are associated with chemoradiotherapy resistance in colorectal cancer"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ", while in glioblastoma, increased expression of H2A.J correlates with poor responsiveness to temozolomide through activation of inflammatory pathways involving TNF-α/NF-κB and IL-6/STAT3."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Differential expression of H2A.J has also been observed in melanoma progression, where its altered transcript levels serve as promising diagnostic or prognostic markers"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ", and it has been implicated among key genes associated with therapy resistance in hepatocellular carcinoma."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these studies highlight that H2A.J not only contributes to the maintenance of chromatin integrity under physiological conditions but also actively modulates gene expression programs linked to senescence, inflammation, and therapeutic resistance in cancer. Its diverse roles position H2A.J as both a potential biomarker and a therapeutic target across a spectrum of age-associated and malignant disorders.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kévin Contrepois, Clément Coudereau, Bérénice A Benayoun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Histone variant H2A.J accumulates in senescent cells and promotes inflammatory gene expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms14995"}], "href": "https://doi.org/10.1038/ncomms14995"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28489069"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28489069"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Christophe E Redon, Zoe Schmal, Gargi Tewary, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Histone Variant H2A.J Is Enriched in Luminal Epithelial Gland Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes (Basel) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/genes12111665"}], "href": "https://doi.org/10.3390/genes12111665"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34828271"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34828271"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Hiroki Tanaka, Shoko Sato, Masako Koyama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biochemical and structural analyses of the nucleosome containing human histone H2A.J."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biochem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jb/mvz109"}], "href": "https://doi.org/10.1093/jb/mvz109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31793981"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31793981"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xiaojie Wang, Waleed M Ghareeb, Xingrong Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Coexpression network analysis linked H2AFJ to chemoradiation resistance in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.28319"}], "href": "https://doi.org/10.1002/jcb.28319"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30565747"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30565747"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Hsun-Hua Lee, Che-Hsuan Lin, Hui-Yu Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancers (Basel) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/cancers12010098"}], "href": "https://doi.org/10.3390/cancers12010098"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31906036"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31906036"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "N J W de Wit, J Rijntjes, J H S Diepstra, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.bjc.6602612"}], "href": "https://doi.org/10.1038/sj.bjc.6602612"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15900300"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15900300"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jing Liu, Wan Cheng Qiu, Xiao Ying Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bioinformatics analysis revealed hub genes and pathways involved in sorafenib resistance in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Math Biosci Eng (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3934/mbe.2019315"}], "href": "https://doi.org/10.3934/mbe.2019315"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31698564"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31698564"}]}]}]}
NCBI Gene ID 55766
API
Download Associations
Predicted Functions View H2AJ's ARCHS4 Predicted Functions.
Co-expressed Genes View H2AJ's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View H2AJ's ARCHS4 Predicted Functions.

Functional Associations

H2AJ has 1,837 functional associations with biological entities spanning 6 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 28 datasets.

Click the + buttons to view associations for H2AJ from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of H2AJ gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of H2AJ gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CellMarker Gene-Cell Type Associations cell types associated with H2AJ gene from the CellMarker Gene-Cell Type Associations dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of H2AJ gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with H2AJ protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with H2AJ gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with H2AJ gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
GO Biological Process Annotations 2025 biological processes involving H2AJ gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2025 cellular components containing H2AJ protein from the curated GO Cellular Component Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of H2AJ gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of H2AJ gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of H2AJ gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of H2AJ gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of H2AJ gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
KEGG Pathways 2026 pathways involving H2AJ protein from the KEGG Pathways 2026 dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of H2AJ gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of H2AJ gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
PFOCR Pathway Figure Associations 2024 pathways involving H2AJ protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2024 pathways involving H2AJ protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of H2AJ gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of H2AJ gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of H2AJ gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of H2AJ gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of H2AJ gene from the Sci-Plex Drug Perturbation Signatures dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of H2AJ protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of H2AJ protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with H2AJ protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2024 pathways involving H2AJ protein from the WikiPathways Pathways 2024 dataset.